Vital Images to use iCAD technology
This article was originally published in The Gray Sheet
Executive Summary
iCAD's Second Look CT computer-aided detection (CAD) will be integrated, pending FDA approval, into the firm's Vitrea 2 medical imaging software for diagnostic evaluation of CT and MR image data to detect polyps that could lead to colon cancer under a non-exclusive agreement. Vital Images inked a July deal with CAD-competitor R2 Technology to incorporate the latter firm's ImageChecker CT system with Vitrea 2 for lung nodules (1"The Gray Sheet" July 19, 2004, p. 22). Vital Images is a distributor for R2...
You may also be interested in...
R2 ImageChecker Approval Launches CAD Lung Market; iCAD Preps To Join
FDA approval of R2 Technology's ImageChecker CT CAD system for lung nodules July 8 provides the firm with a comfortable head-start over competitor iCAD, which expects to launch its own system in 2005
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: